Thalidomide Enhances Clinical Efficacy Of Cetuximab Combined With Standard Chemotherapy For Left Colorectal Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Thalidomide Enhances Clinical Efficacy Of Cetuximab Combined With Standard Chemotherapy For Left Colorectal Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06279351

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

1. To verify that thalidomide can increase the efficacy of cetuximab plus chemotherapy in the treatment of stage IV RAS and BRAF wild-type unresectable left col…

China96 participantsStarted 2024-08-11

Treatment: Thalidomide+cetuximab+FOLFOX/FOLFIRI

Thalidomide Enhances Clinical Efficacy Of Cetuximab Combined With Standard Chemotherapy For Left Colorectal Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

All recent trials (1 shown)